We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.28%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.82B
AUM Growth
+$324M
Cap. Flow
-$120M
Cap. Flow %
-6.62%
Top 10 Hldgs %
36.31%
Holding
2,419
New
1,036
Increased
430
Reduced
305
Closed
497

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Consumer Discretionary 5.02%
3 Healthcare 3.42%
4 Financials 2.97%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAX
1601
DELISTED
J. Alexander's Holdings, Inc.
JAX
$9K ﹤0.01%
+1,839
New +$8.36K
RLH
1602
DELISTED
Red Lions Hotel Corporation
RLH
$9K ﹤0.01%
+3,726
New +$6.67K
MACK
1603
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$9K ﹤0.01%
+2,800
New +$9.56K
ALLY icon
1604
CALL
Ally Financial
ALLY
$13.4B
$8K ﹤0.01%
400
-1,300
-76% -$22.1K
AN icon
1605
PUT
AutoNation
AN
$6.89B
$8K ﹤0.01%
+200
New +$7.24K
ERII icon
1606
Energy Recovery
ERII
$414M
$8K ﹤0.01%
1,100
+700
+175% +$5.54K
FSTR icon
1607
Foster
FSTR
$411M
$8K ﹤0.01%
655
-500
-43% -$6.43K
GPC icon
1608
Genuine Parts
GPC
$18.5B
$8K ﹤0.01%
+93
New +$7.34K
IPO icon
1609
CALL
Renaissance IPO ETF
IPO
$161M
$8K ﹤0.01%
+200
New +$6.77K
MO icon
1610
CALL
Altria Group
MO
$111B
$8K ﹤0.01%
+200
New +$7.8K
NBIX icon
1611
Neurocrine Biosciences
NBIX
$16.7B
$8K ﹤0.01%
+65
New +$7.18K
OMCL icon
1612
Omnicell
OMCL
$1.71B
$8K ﹤0.01%
+115
New +$7.87K
PLAY icon
1613
CALL
Dave & Buster's
PLAY
$344M
$8K ﹤0.01%
+600
New +$8K
RHI icon
1614
Robert Half
RHI
$4.33B
$8K ﹤0.01%
+144
New +$6.84K
SHY icon
1615
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$8K ﹤0.01%
+97
New +$8.4K
SIG icon
1616
PUT
Signet Jewelers
SIG
$3.68B
$8K ﹤0.01%
+800
New +$7.91K
STGW icon
1617
Stagwell
STGW
$2.19B
$8K ﹤0.01%
+4,051
New +$5.39K
VREX icon
1618
Varex Imaging
VREX
$776M
$8K ﹤0.01%
541
BIG
1619
PUT
DELISTED
Big Lots, Inc.
BIG
$8K ﹤0.01%
+200
New +$5.68K
RDS.A
1620
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$8K ﹤0.01%
+238
New +$8.16K
CSOD
1621
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$8K ﹤0.01%
+200
New +$7.04K
LDL
1622
DELISTED
Lydall, Inc.
LDL
$8K ﹤0.01%
564
-600
-52% -$6.64K
GEN
1623
DELISTED
Genesis Healthcare, Inc.
GEN
$8K ﹤0.01%
+12,314
New +$9.9K
MNK
1624
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$8K ﹤0.01%
3,010
+2,910
+2,910% +$8.73K
PFNX
1625
DELISTED
Pfenex Inc.
PFNX
$8K ﹤0.01%
+900
New +$6.73K

Similar funds

Prelude Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Prelude Capital Management held 2,419 positions worth $1.82B, up 22% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Prelude Capital Management withdrew a net $120M in Q2 2020, closing 497 positions and reducing 305 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in iShares 0-5 Year High Yield Corporate Bond ETF worth $24.4M.

  • Prelude Capital Management's largest Q2 2020 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 568,440 shares worth $24.4M.
  • Prelude Capital Management added most to Acacia Communications Inc in Q2 2020, an estimated $3.72M increase.
  • Prelude Capital Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $8.71M.
  • Prelude Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.1M.
  • Prelude Capital Management's ten largest holdings make up 36% of its $1.82B portfolio in Q2 2020.
  • Prelude Capital Management opened 1,036 new positions and closed 497 in Q2 2020.
  • Prelude Capital Management's portfolio value rose 22% quarter-over-quarter to $1.82B.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.